Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2002
10/30/2002EP1251868A1 Combination therapy for the treatment of inflammatory and respiratory diseases
10/30/2002EP1251866A1 Combination of temozolomide and pegylated interferon-alpha for treating cancer
10/30/2002EP1251862A1 Ophthalmic compositions for treating ocular hypertension
10/30/2002EP1251859A1 Novel compounds
10/30/2002EP1251858A2 Podophyllotoxin compositions
10/30/2002EP1251857A1 Pharmaceutical parenteral composition containing a bisphosphonate
10/30/2002EP1251856A1 Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices
10/30/2002EP1251855A1 Selective estrogen receptor modulators in combination with estrogens
10/30/2002EP1251854A2 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone
10/30/2002EP1251853A1 Transdermal therapeutic system for the administration of zaleplon
10/30/2002EP1251852A1 Use of desloratadine for treating allergic and inflammatory conditions
10/30/2002EP1251851A1 Treating allergic and inflammatory conditions
10/30/2002EP1251850A2 Combination therapy for cancer
10/30/2002EP1251849A1 Gyrase inhibitors and uses thereof
10/30/2002EP1251848A1 Gyrase inhibitors and uses thereof
10/30/2002EP1251847A1 Novel use of prodigiosin for treating diabetes mellitus
10/30/2002EP1251846A1 C-4 carbonate taxanes
10/30/2002EP1251845A1 Purifying polyoxyethylated castor oils with activated charcoal and pharmaceutical formulations thereof
10/30/2002EP1251844A2 Laxative preparation containing l-arginine
10/30/2002EP1251843A1 Compositions for delivery of a cortisol antagonist
10/30/2002EP1251842A2 Use of modafinil for making a medicine for correcting disorders affecting vigilance related to myopathies
10/30/2002EP1251841A1 Aqueous solution for treating degenerative or autoimmune diseases and as immunomodulatory agent
10/30/2002EP1251840A2 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor
10/30/2002EP1251839A2 Use of cox-2 inhibitors for the treatment of constipation
10/30/2002EP1251838A2 Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor
10/30/2002EP1251837A2 Compounds and methods for modulating cerebral amyloid angiopathy
10/30/2002EP1251836A2 Use of bvdu for inhibiting the growth of hyperproliferative cells
10/30/2002EP1251832A2 Shell-and-core dosage form approaching zero-order drug release
10/30/2002EP1251831A1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor
10/30/2002EP1251830A1 Continuous method for preparing pharmaceutical granules
10/30/2002EP1251828A1 Local drug delivery using photosensitizer-mediated and electromagnetic radiation-enhanced vascular permeability
10/30/2002EP1251826A1 Diclofenamide suspension gel
10/30/2002EP1251818A1 Galenic formulation
10/30/2002EP1251750A1 Improved pediatric formula and methods for providing nutrition and improving tolerance
10/30/2002EP1251739A2 Poly(dipeptide) as a drug carrier
10/30/2002EP1251738A1 Novel diphenylethylene compounds
10/30/2002EP1251737A2 Compositions treated to inactivate infectious proteins
10/30/2002EP1204667A4 An improved amorphous form of cefpodoxime proxetil
10/30/2002EP1155018B1 Crystal modification c of 8-cyano-1-cyclopropyl-7- (1s, 6s-2,8- diazabicyclo - 4.3.0] nonan-8-yl) -6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic
10/30/2002EP1152731A4 A skin care composition that mediates cell to cell communication
10/30/2002EP1140242B1 Polymer compositions for intraluminal stent
10/30/2002EP1137416B1 Use of long-chain n-alkyl derivatives of deoxynojirimycin for the manufacture of a medicament for the treatment of glycolipid storage diseases
10/30/2002EP1135193B1 Agents provided for treating tumors, based on liposomes, and containing tamoxifen
10/30/2002EP1090017B1 Novel compounds derived from alpha-d-xylose, preparation method and therapeutic use
10/30/2002EP1066294B1 Novel process for the fermentative production of cephalosporin
10/30/2002EP1061925B1 Combination of a gaba-a alpha 5 inverse agonist and a nicotinic agonist
10/30/2002EP1051425B1 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
10/30/2002EP1032264A4 Method of enhancing the antimicrobial properties of antibacterial antibiotics
10/30/2002EP1011634B1 Preparation of pharmaceutical compositions
10/30/2002EP1005449B1 3-aryl-succinamido-hydroxamic acids, methods for producing said acids and medicaments containing the same
10/30/2002EP0996613B1 Pure cis-tramadol hydrochloride production
10/30/2002EP0991410B1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
10/30/2002EP0971707B1 Compositions for the treatment of burns and external ulcers and a process for the preparation thereof
10/30/2002EP0854863B1 Esters and amides as pla2 inhibitors
10/30/2002EP0852225B1 Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
10/30/2002EP0851763B1 Method and composition for enhanced parenteral nutrition
10/30/2002EP0831835B1 Treating anorexia
10/30/2002EP0828495B1 Stabilized solid dispersions of misoprostol
10/30/2002EP0827393B1 Pharmaceutical composition prepared by addition of a flavour vehicle to a medicament
10/30/2002EP0812195B1 Pharmaceutical composition for piperidinoalkanol compounds
10/30/2002EP0811635B1 Intravascular membrane thickening inhibitor
10/30/2002EP0799221B1 Quinazolines as inhibitors of endothelin converting enzyme
10/30/2002EP0793660B1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
10/30/2002EP0775126B1 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
10/30/2002EP0732927B1 Compositions containing in particular, riboflavin, for the local prevention of diseases of the genital and rectal mucus membranes
10/30/2002EP0695187B1 Inhibition, control and regression of angiogenesis with hyaluronic acid or hyaluronic acid and nsaid
10/30/2002CN1377410A Nucleic acids and proteins from group B streptoccus
10/30/2002CN1377368A 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
10/30/2002CN1377367A Sapogenin derivatives and their use in the treatment of cognitive dysfunction
10/30/2002CN1377366A 5-hydroxysapogenin derivatives with anti-dementia activity
10/30/2002CN1377365A Eplerenone crystalline form exhibiting enhanced dissolution rate
10/30/2002CN1377364A Resticidal macrolides
10/30/2002CN1377363A Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
10/30/2002CN1377357A Pyrazolo [4,3-d] pyrimidines
10/30/2002CN1377356A Certain alkylene diamine-substituted heterocycles
10/30/2002CN1377355A Amino substituted pyrazolo [1,5-2]-1,5-pyrimidines and pyrazolo [1,5-2]-1,3, 5-triazines
10/30/2002CN1377354A Certain alkylene diamine-substituted pyrazolo [1,5-a]-1,5-pyrimidines and pyrazolo [1,5-a]-1,3,5-triazines
10/30/2002CN1377353A Purine derivatives having phosphodiesterase IN inhibition activity
10/30/2002CN1377352A Selective antagonists of A28 adenosine receptors
10/30/2002CN1377349A Quiunclidine compounds and drugs containing the same as the active ingredient
10/30/2002CN1377348A 4,5-diaryloxazole compounds with prostaglandin 12 (PG12) agonistic activity
10/30/2002CN1377347A 药学活性磺酰胺衍生物 Pharmaceutically active sulfonamide derivatives
10/30/2002CN1377346A Z-pyrazoline-5-ones
10/30/2002CN1377344A Inhibitor of cysteinyl aspartic acid proteinase
10/30/2002CN1377341A Amycomycin, production thereof and its use as pharmaceutical
10/30/2002CN1377282A Fatty acid-anticancer conjugates and uses thereof
10/30/2002CN1377277A Use of leptin in inhibition of endothelial cell proliferation
10/30/2002CN1377273A Antiobestic agents
10/30/2002CN1377272A Agents for intravitreal administration to treat or prevent disorders of the eye
10/30/2002CN1377271A Use of thienopyrimidines
10/30/2002CN1377270A B-carboline drug products
10/30/2002CN1377269A Vitronectin receptor antagonists
10/30/2002CN1377268A Cell adhesion inhibitors
10/30/2002CN1377267A Retard form containing 2-lipoic acid (derivatives)
10/30/2002CN1377266A Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
10/30/2002CN1377265A Use of agonists of gabab receptors and pharmaceutically acceptable derivates thereof, in the therapy of maintaining nicotine abstinence-dependent patients
10/30/2002CN1377264A Method for treating endometriosis or infertility, or improving fertility
10/30/2002CN1377263A Neuropathy improves containing nitrogenous compounds as the active ingredient
10/30/2002CN1377262A Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses
10/30/2002CN1377261A Treatment of immune diseases
1 ... 5666 5667 5668 5669 5670 5671 5672 5673 5674 5675 5676 5677 5678 5679 5680 5681 5682 5683 5684 5685 5686 ... 7860